The opposition warns of the effects of the financial crisis on state drugs and medicines

Opposition parties and trade union structures renewed their criticism of the government's supply and finance policies in conjunction with the discussion of the draft state budget for 2027 in November 2026. Opposition circles and experts have warned of the repercussions of the financial crisis affecting key state drugs, most notably the Department of Grains, Commerce and Pharmacy.

Public institutions face funding constraints that affect their ability to pay the debts of international suppliers and global pharmaceutical companies in contractual terms. This shortage is causing a continuing shortage and disruption of a number of life-saving drugs targeted at patients with chronic diseases, tumors and kidney disease, as well as fluctuations in supplies of consumables including sugar, rice, flour, manure and coffee in several states.

Opposition forces have criticized the authority's reliance on direct domestic borrowing from the central bank and local banks to cover transportation expenses, believing that this dries up available liquidity for private investment financing and fuels inflation. Opposition parties said the official approach limited the crisis to speculation and monopoly, ignoring structural problems of religious service and financial deficit.

The economic arena is witnessing trade union demands to revise the wage ladder and stop the bleeding of skilled migration from doctors and engineers amid rising prices and declining purchasing power. Opposition elements have called for a comprehensive economic dialogue to formulate a rescue programme that protects affected production systems from drought, high cost of inputs and reassesses public institutions.

Opposition forces and figures and expert reports had earlier warned of a deterioration in financial indicators and the deficit of the central pharmacy to coincide with the start of debate on the 2027 budget.